New York, Jan 9, 2026, 06:19 EST — Premarket
China SXT Pharmaceuticals Inc shares ended Thursday down 37.5% at $1.25 after swinging between $1.21 and $6.98, with volume jumping to about 109.3 million shares, Yahoo Finance data showed. The day before, the stock closed at $2.00 on roughly 115,000 shares.
The China-based maker of traditional Chinese medicine products said it launched a “Strategic Artificial Intelligence (AI) Insights Initiative” to apply AI analytics to product planning, market intelligence and research decisions, and it plans offline AI-supported consultation stores across China. “Leveraging AI to gain insight into product trends and market dynamics is both a logical and necessary step,” co-chief executive officer Feng Zhou said. GlobeNewswire
The move matters now because SXTC is thinly traded and small news can get amplified, especially when it touches on a theme investors are already scanning for. Barchart data put first resistance — a level where selling often gathers — near $5.08, with the stock’s 52-week range at $0.95 to $7.84.
In extended trade after the close, the stock was quoted around $1.48, up about 18%, according to MarketWatch data. That would still leave it far below Thursday’s intraday high.
But China SXT did not lay out the cost of its AI work and store rollout, a timetable for opening the first locations, or how it expects to handle regulation and consumer trust around AI-guided health services. If volume drops back, the stock’s next move can turn sharply on a handful of orders.
Outside the company, traders also have a macro catalyst on deck: the U.S. Employment Situation report is due at 8:30 a.m. EST, a release that can swing risk appetite ahead of the cash open.
Next up is that 8:30 a.m. data and the first prints after 9:30 a.m., with traders watching whether Thursday’s surge in activity proves sticky or fades as fast as it arrived.
